No Revenues in Q3 for SQI | GenomeWeb

NEW YORK (GenomeWeb News) – SQI Diagnostics reported after the close of the market on Tuesday that it had no revenues for its fiscal third quarter, compared to C$9,000 (US$9,064) from the year-ago period.

In documents filed with SEDAR, the Canadian financial information filing system, Toronto-based SQI said that the revenue drop resulted from one customer, Gamma Dynacare Medical Labs, choosing not to purchase QuantiSpot RA test kits in the quarter. Subsequent to the end of the third quarter, GDML reordered the kits.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The White House has created a list of cuts, including to the NIH, that could be in a budget bill for this year.

The US National Institutes of Health is to allow applicants to cite preprints just as they would any other research paper, ScienceInsider reports.

Two manuscript pages handwritten by Charles Darwin are going on the auction block, according to the Los Angeles Times.

In PNAS this week: tool to track transcriptome-wide binding, evidence of balancing selection on behavior-linked genes, and more.